231 related articles for article (PubMed ID: 30662082)
21. Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia.
Touch S; Oh JK
BMC Cancer; 2018 Mar; 18(1):294. PubMed ID: 29544466
[TBL] [Abstract][Full Text] [Related]
22. Upgrading public health programs for human papillomavirus prevention and control is possible in low- and middle-income countries.
Steben M; Jeronimo J; Wittet S; Lamontagne DS; Ogilvie G; Jensen C; Smith J; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F183-91. PubMed ID: 23199962
[TBL] [Abstract][Full Text] [Related]
23. Cervical Cancer, Human Papillomavirus Infection, and Vaccine-Related Knowledge: Awareness in Chinese Women.
Yuanyue L; Baloch Z; Shanshan L; Yasmeen N; Xiaomei W; Khan JM; Xueshan X
Cancer Control; 2018; 25(1):1073274818799306. PubMed ID: 30213198
[TBL] [Abstract][Full Text] [Related]
24. Human Papillomavirus Vaccine as an Anticancer Vaccine: Collaborative Efforts to Promote Human Papillomavirus Vaccine in the National Comprehensive Cancer Control Program.
Townsend JS; Steele CB; Hayes N; Bhatt A; Moore AR
J Womens Health (Larchmt); 2017 Mar; 26(3):200-206. PubMed ID: 28263672
[TBL] [Abstract][Full Text] [Related]
25. Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014.
Ladner J; Besson MH; Audureau E; Rodrigues M; Saba J
BMC Health Serv Res; 2016 Oct; 16(1):575. PubMed ID: 27737666
[TBL] [Abstract][Full Text] [Related]
26. Knowledge of Cervical Cancer, Human Papilloma Virus (HPV) and HPV Vaccination Among Women in Northeast China.
Ning YE; Liu Y; Xu XY; Zhang XY; Wang N; Zheng LQ
J Cancer Educ; 2020 Dec; 35(6):1197-1205. PubMed ID: 31338812
[TBL] [Abstract][Full Text] [Related]
27. [Cervical cancer prevention: the impact of HPV vaccination].
Monsonégo J
Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
[TBL] [Abstract][Full Text] [Related]
28. [Expert consensus on immunological prevention of human papillomavirus-related diseases].
Vaccine and Immunization Branch, Chinese Preventive Medicine Association
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Aug; 53(8):761-803. PubMed ID: 31378039
[TBL] [Abstract][Full Text] [Related]
29. The need for public education on HPV and cervical cancer prevention in Asia. Opinions of experts at the AOGIN conference.
Garland S; Park SN; Ngan HY; Frazer I; Tay EH; Chen CJ; Bhatla N; Pitts M; Shin HR; Konno R; Smith J; Pagliusi S; Park JS
Vaccine; 2008 Oct; 26(43):5435-40. PubMed ID: 18706952
[TBL] [Abstract][Full Text] [Related]
30. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
[TBL] [Abstract][Full Text] [Related]
31. Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing.
Chrysostomou AC; Stylianou DC; Constantinidou A; Kostrikis LG
Viruses; 2018 Dec; 10(12):. PubMed ID: 30572620
[TBL] [Abstract][Full Text] [Related]
32. Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study.
Lim ASE; Lim RBT
Vaccine; 2019 Sep; 37(41):6030-6038. PubMed ID: 31473002
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia.
Shi JF; Qiao YL; Smith JS; Dondog B; Bao YP; Dai M; Clifford GM; Franceschi S
Vaccine; 2008 Aug; 26 Suppl 12():M53-9. PubMed ID: 18945414
[TBL] [Abstract][Full Text] [Related]
35. High-risk human papillomavirus genotypes in cervical lesions and vaccination challenges in China.
Xu QX; Zhang ZY
Asian Pac J Cancer Prev; 2015; 16(6):2193-7. PubMed ID: 25824736
[TBL] [Abstract][Full Text] [Related]
36. Cervical cancer in Ethiopia: a review of the literature.
Derbie A; Mekonnen D; Nibret E; Misgan E; Maier M; Woldeamanuel Y; Abebe T
Cancer Causes Control; 2023 Jan; 34(1):1-11. PubMed ID: 36242682
[TBL] [Abstract][Full Text] [Related]
37. Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none.
El-Zein M; Richardson L; Franco EL
J Clin Virol; 2016 Mar; 76 Suppl 1(Suppl 1):S62-S68. PubMed ID: 26631958
[TBL] [Abstract][Full Text] [Related]
38. Awareness of Turkish female adolescents and young women about HPV and their attitudes towards HPV vaccination.
Ozyer S; Uzunlar O; Ozler S; Kaymak O; Baser E; Gungor T; Mollamahmutoglu L
Asian Pac J Cancer Prev; 2013; 14(8):4877-81. PubMed ID: 24083762
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus vaccine disease impact beyond expectations.
de Sanjose S; Brotons M; LaMontagne DS; Bruni L
Curr Opin Virol; 2019 Dec; 39():16-22. PubMed ID: 31382121
[TBL] [Abstract][Full Text] [Related]
40. Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis.
Burger EA; de Kok IMCM; Groene E; Killen J; Canfell K; Kulasingam S; Kuntz KM; Matthijsse S; Regan C; Simms KT; Smith MA; Sy S; Alarid-Escudero F; Vaidyanathan V; van Ballegooijen M; Kim JJ
J Natl Cancer Inst; 2020 Sep; 112(9):955-963. PubMed ID: 31821501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]